This inventor holds 21 USPTO granted patents and 3 published patent applications, plus 5 CIPO patents and 16 EPO patents, primarily in Immunogenic Compositions. Top assignees: Wyeth Holdings Corporation, Serono Genetics Institute S.a., American Cyanamid Company. Active years: 1997-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
12 out of 113 
5 out of 62 
1 out of 3,580 
Years Active: 1997-2021
Areas of Expertise:
Title: Benjamin J Metcalf: Innovator in Meningococcal Disease Prevention
Introduction
Benjamin J Metcalf, a prominent inventor located in Rochester, NY, has made significant contributions to the field of immunology with a total of 21 patents to his name. His work focuses on developing innovative solutions for the prevention and treatment of meningococcal disease, showcasing his dedication to advancing medical science.
Latest Patents
Among his latest patents, Benjamin has developed immunogenic compositions effective against meningococcal disease. His work specifically relates to ORF2086 proteins, which are cross-reactive immunogenic proteins that can be isolated from neisserial strains or prepared recombinantly. These compositions include immunogenic portions, biological equivalents, antibodies that bind specifically to these proteins, and nucleic acid sequences encoding them. The inventions offer promising uses in immunogenic compositions that are effective against infections caused by serogroup B.
Career Highlights
Throughout his career, Benjamin has worked with notable companies such as Wyeth Holdings Corporation and Serono Genetics Institute S.A. His experience in these organizations has played a pivotal role in shaping his expertise in immunological research and patent development.
Collaborations
In his professional journey, Benjamin has collaborated with esteemed colleagues like Leah Diane Fletcher and Robert J Zagursky. These collaborations have further enriched his research endeavors and contributed to his innovative outputs in the field.
Conclusion
Benjamin J Metcalf's contributions to the development of immunogenic compositions demonstrate his innovative spirit and commitment to advancing healthcare solutions. With his extensive portfolio of patents and collaborative efforts, he continues to be a key figure in the fight against meningococcal disease, paving the way for future advancements in immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile